Cargando…

High rates of medication adherence in patients with pulmonary arterial hypertension: An integrated specialty pharmacy approach

Phosphodiesterase-5 inhibitors (PDE-5I) have demonstrated improvement in disease symptoms and quality of life for patients with pulmonary arterial hypertension (PAH). Despite these benefits, reported adherence to PDE-5I therapy is sub-optimal. Clinical pharmacists at an integrated practice site are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Nisha B., Mitchell, Rhonita E., Proctor, Stephanie Terry, Choi, Leena, DeClercq, Joshua, Jolly, Jacob A., Hemnes, Anna R., Zuckerman, Autumn D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553732/ https://www.ncbi.nlm.nih.gov/pubmed/31170217 http://dx.doi.org/10.1371/journal.pone.0217798

Ejemplares similares

Pharmacist Interventions to Improve Specialty Medication Adherence: Study Protocol for a Randomized Controlled Trial
por: Kibbons, Amanda M., et al.
Publicado: (2020)

Adherence and persistence in patients with rheumatoid arthritis at an integrated health system specialty pharmacy
por: Peter, Megan E, et al.
Publicado: (2021)

Primary medication nonadherence rates to specialty disease-modifying antirheumatic drugs for rheumatoid arthritis within a health system specialty pharmacy
por: Petry, Laura, et al.
Publicado: (2023)

Impact of specialty pharmacist integration on time to medication access for pimavanserin
por: Livezey, Sabrina, et al.
Publicado: (2019)

Specialty pharmacist integration into an outpatient neurology clinic improves pimavanserin access
por: Livezey, Sabrina, et al.
Publicado: (2021)

Inclusion in limited distribution drug network reduces time to dalfampridine access in patients with multiple sclerosis at a health-system specialty pharmacy
por: Peter, Megan E, et al.
Publicado: (2021)

Low rates of primary medication nonadherence in patients prescribed oral oncology agents across health system specialty pharmacies
por: Zuckerman, Autumn, et al.
Publicado: (2023)

An Integrated Health-System Specialty Pharmacy Model for Coordinating Transitions of Care: Specialty Medication Challenges and Specialty Pharmacist Opportunities
por: Zuckerman, Autumn D., et al.
Publicado: (2019)

Development of a collaborative pharmacy practice agreement to improve efficiency and management of prescribing in a renal transplant clinic
por: Chelewski, Rachel, et al.
Publicado: (2019)

981. Extended Adherence and Persistence to HIV PrEP in a Multidisciplinary PrEP Clinic
por: Whelchel, Kristen, et al.
Publicado: (2020)

Incidence and Impact of Persistent Viremia on SVR Rates in Patients Receiving Direct-Acting Antiviral Therapy
por: Carver, Alicia B, et al.
Publicado: (2020)

Predicting time to medication access for hematologic malignancies: the impact of an integrated specialty pharmacy and limited distribution drug networks
por: Zuckerman, Autumn D., et al.
Publicado: (2019)

Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: Does coinfection really matter?
por: Zuckerman, Autumn D., et al.
Publicado: (2019)

Adherence to oral oncolytics filled through an internal health-system specialty pharmacy compared with external specialty pharmacies
por: Academia, Emmeline C, et al.
Publicado: (2021)

988. Overcoming Prescriber Concerns through Successful Access and Affordability of PrEP
por: Whelchel, Kristen, et al.
Publicado: (2020)

Adherence of patients to oral oncolytic and neurologic specialty medications provided by a specialty pharmacy
por: Bhusal, Binita, et al.
Publicado: (2019)

Impact of outpatient specialty pharmacy on medication adherence in post-kidney transplant patients
por: Petrosan, Adina, et al.
Publicado: (2019)

Exploring healthcare providers’ experiences with specialty medication and limited distribution networks
por: Peter, Megan E., et al.
Publicado: (2022)

Impact of health-system specialty pharmacy services on medication adherence in pediatric patients with cystic fibrosis
por: Tao, Vincent, et al.
Publicado: (2019)

The Emergence of Specialty Pharmacy
por: Vanscoy, Gordon J.
Publicado: (2020)

The Reemergence of Specialty Pharmacy
por: Vanscoy, Gannon, et al.
Publicado: (2020)

Development of a specialty pharmacy productivity benchmarking model
por: Platt, Thom, et al.
Publicado: (2019)

Management of specialty drugs, specialty pharmacies and biosimilars in the United States
por: Brook, Richard A., et al.
Publicado: (2019)

Best Practices in Specialty Pharmacy Management
por: Patterson, Courtney J.
Publicado: (2013)

The National Association of Specialty Pharmacy Abstract Program
por: Brook, Richard A., et al.
Publicado: (2019)

Case Report of Specialty Pharmacy Management of Hemophilia
por: Gilbert, Aggie, et al.
Publicado: (2011)

Impact of a specialty pharmacy benefit on rheumatoid arthritis medication adherence and functional status: a continuation study
por: Kozlicki, Miranda, et al.
Publicado: (2019)

Adherence to cystic fibrosis transmembrane conductance regulator (CFTR) modulators: analysis of a national specialty pharmacy database
por: Mehta, Zumi, et al.
Publicado: (2021)

A Comparison of Pharmacy Dispensing Channel Use and Adherence to Specialty Drugs Among Medicare Part D Beneficiaries
por: Kale, Hrishikesh P., et al.
Publicado: (2018)

Development of a palivizumab specialty pharmacy management program
por: Harlan, Lana, et al.
Publicado: (2019)

Evaluation of a specialty pharmacy health coaching program
por: Simonson, Dana, et al.
Publicado: (2019)

1577. HIV Viral Load Suppression in Patients Utilizing an Integrated Health System Specialty Pharmacy Compared to a Non-integrated Specialty Pharmacy Model
por: Jordan, Monica Y Hinestroza, et al.
Publicado: (2023)

Estimating the value of pharmacist interventions in a specialty pharmacy setting
por: Knowles, Grant
Publicado: (2019)

2021 National Association of Specialty Pharmacy: Research Presentation Abstracts
por: Arquette, Sheila, et al.
Publicado: (2021)

Primary Biliary Cholangitis: Medical and Specialty Pharmacy Management Update
por: Bowlus, Christopher L., et al.
Publicado: (2016)

Specialty pharmacy turnaround time impediments, facilitators, and good practices
por: Gabriel, Meghan Hufstader, et al.
Publicado: (2022)

POSC374 Association of COVID-19 on Adherence to Oral Specialty Pharmacy Oncology Medications and Quality of Life of Multiple Myeloma Patients
por: Burruss, R, et al.
Publicado: (2022)

Advancing Pharmacy Practice in Tanzania: A Descriptive Report of Pharmacy Education and Practice Models in 3 Institutions
por: Mbilinyi, Christian, et al.
Publicado: (2021)

Relationship between pharmacy residency examination rank and specialty choice for French pharmacy residency-admitted students
por: Fardel, Olivier
Publicado: (2017)

Implementation of an internal check of oral oncolytics: a single-center, specialty pharmacy safety initiative
por: Hughes, Mitchell, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1fnmpojn3088e4p5r7s58ab79r